Hers vs Eden: Advertised vs All-In GLP-1 Pricing Compared

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Welcome to the PlexusDx Education Hub, where we translate GLP-1 science, weight-management options, and the genetics beneath them into decisions you can actually use. Explore the full Peptides & GLP-1 library.

This is independent editorial coverage. PlexusDx holds no affiliate, sponsorship, or commercial tie to Hers, Eden, or their parent companies, and no links here pay us.

Full head-to-head: PlexusDx vs Eden →

The Hers versus Eden question almost always comes down to price, and Eden is a useful case study in why the advertised number and the number you actually pay can differ. This piece walks through the cost anatomy first, then the program mechanics, the shared pharmacology, and the genetic layer both brands leave out. Figures below reflect what was visible as of July 2026.

The advertised price versus the all-in price

Eden's advertised price is $99/month for compounded semaglutide and $199/month for tirzepatide, medication only. A required Eden Membership ($99/month, disclosed in Eden's own footnote) brings the true all-in cost to $198/month for semaglutide and $298/month for tirzepatide: the number a shopper remembers is $99, the number they pay is $198. Eden figures verified at checkout, July 2026. Hers publishes its own weight-loss pricing that varies by medication and plan, so verify current Hers rates at Hers's official website before deciding.

How Eden structures the program

Beyond the headline, Eden bills monthly only, dispenses injections only, and charges nothing until a provider approves your request. It also attaches a money-back warranty: lose 10% of your body weight in six months or get your money back. Those mechanics matter as much as the sticker, because a monthly-only, injection-only structure with a conditional guarantee behaves very differently from a prepaid bundle.

Same compounds behind both storefronts

Hers (Hims & Hers Health) and Eden both prescribe within the GLP-1 receptor agonist class. GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, and the GIP/GLP-1 dual agonist tirzepatide, modulate appetite, satiety, and gastric emptying. The molecule dictates the biology; the brand dictates the price and packaging. That is precisely why comparing all-in monthly cost, not advertised cost, is the honest comparison.

Where PlexusDx sits on price

For a direct reference point, PlexusDx runs month-to-month at $189 for Semaglutide Injection and $289 for Tirzepatide Injection, with Semaglutide Oral at $289/month and Tirzepatide Oral at $349/month. Against Eden's all-in figures of $198 for semaglutide and $298 for tirzepatide (verified July 2026), the injectable protocols land modestly lower while adding something Eden does not: upstream genetic context.

The evidence and the missing genetic layer

The compound class carries a deep trial record: STEP for semaglutide in weight management (NEJM 2021), SURMOUNT for tirzepatide (NEJM 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM 2024). Yet no pricing page addresses the genetics underneath your response. Variants in FTO (the fat-mass and obesity-associated gene), TCF7L2 (linked to glucose homeostasis and GLP-1 secretion), GLP1R, and MC4R map your baseline metabolic terrain. They are pathway-level and do not predict response to any specific compound.

The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, covering the FTO, MC4R, and TCF7L2 variants that shape appetite regulation and energy balance. Paired with the PlexusDx Weight Management Protocols, it is the test before you invest approach: understand the biology before you commit a monthly budget to it.

No affiliation: PlexusDx has no commercial relationship with Hers or Eden and does not represent either company.

More from the Education Hub: GLP 1 Receptor Agonist and GLP 1 Drugs.

Disclaimer: This comparison is educational. PlexusDx is not affiliated with Hers or Eden. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways and does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Frequently Asked Questions

Why is Eden's real cost higher than the advertised $99?

Because $99/month covers compounded semaglutide medication only. Eden requires a separate membership ($99/month, per its own footnote), which lifts the all-in cost to $198/month for semaglutide and $298/month for tirzepatide, verified at checkout in July 2026. Always read a program's fee footnotes before comparing.

How does Eden's billing model work?

Eden bills monthly only, dispenses injections only, and charges nothing until a provider approves your request. It also offers a money-back warranty tied to losing 10% of body weight in six months. That monthly, injection-only structure differs sharply from programs built around prepaid multi-month bundles.

How does PlexusDx pricing compare with Eden's all-in cost?

PlexusDx runs month to month at $189 for Semaglutide Injection and $289 for Tirzepatide Injection. Against Eden's all-in figures of $198 and $298 (July 2026), the injectable protocols sit modestly lower, and they add pathway-level genetic context through the Precision Peptide Genetic Test that Eden does not offer.

Keep learning at the PlexusDx Education Hub. Return to the Peptides & GLP-1 library.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.